Enhanced retroviral gene transfer into CML and normal bone marrow, and CML and mobilized peripheral blood CD34+ cells using the recombinant fibronectin fragment CH-296

British Journal of Haematology

Volumn 107, Issue 2, 1999, Pages 401-408

  Garrett, Elaine ^a,b   Garin, Marina I ^a   Miller, Angela R M ^a   Goldman, John M ^a   Melo, Junia V ^a   Apperley, Jane F ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

CD34+ progenitor cells; CH 296; Chronic myeloid leukaemia; Cytokines; Retroviral transduction

Indexed keywords

CD34 ANTIGEN; FIBRONECTIN; VIRUS VECTOR;

ARTICLE; BONE MARROW CELL; CELL ISOLATION; CENTRIFUGATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL; VIRUS INFECTION;

ANTIGENS, CD34; BONE MARROW CELLS; CYTOKINES; FIBRONECTINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PEPTIDE FRAGMENTS; RETROVIRIDAE; TRANSFECTION; TRANSFORMATION, GENETIC;

EID: 0032726347     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01703.x     Document Type: Article

References (35)

1. Bazzoni, G., Carlesso, N., Griffin. J.D. & Hemler, M.E. (1996) Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. Journal of Clinical Investigation, 98, 521-528.
2. Bhatia. R. & Verfaillie, C.M. (1998) Inhibition of BCR-ABL expression Vith antiscnse oligodeoxynucleotides restores betal intcgrinmediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors. Blood, 91, 3414-3422.
3. Breems, D.A., Van. D.E., Hawley. R.G.. Siebel, K.E. & Ploemacher, R.E. (1998) Stroma-conditioned medium and sufficient prestimulation improve fibronectin fragment-mediated retroviral gene transfer into human primitive mobilized peripheral blood stem cells through effects on their recovery and transduction efficiency. leukemia, 12, 951-959.
4. Brenner, M.K.. Rill, D.R., Holladay, M.S., Heslop. H.E.. Moen, R.C., Buschle, M., Krance, R.A., Santana, V.M.. Anderson, W.F. & Ihle, J.N. (1993a) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet. 342, 1134-1137.
5. Brenner, M.K., Rill. D.R., Moen. R.C., Krance, R.A., Mirro, J.. Jr. Anderson, W.F. & Ihle, J.N. (1993b) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341, 85-86.
6. Conneally, E., Eaves, C.J. & Humphries, R.K. (1998) Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood, 91, 3487-3493.
7. Cornelia. K., Moore. A.. Leemhuis. T.. Moen, R.C.. Tricot. G.. Leibowitz. D. & Hoffman. R. (1994) Retroviral mediated gene transfer in chronic myelogenous leukaemia. British Journal of Haematology, 87, 308-316.
8. + progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood, 89, 446-456.
9. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
10. Dowding, C., Guo, A.P., Osterholz, J., Siczkowski. M., Goldman. J. & Gordon, M. (1991) Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood, 78, 499-505.
11. Dunbar, C.E., Cottier Fox, M., O'Shaughnessy, J.A.. Doren, S., Carter, C., Berenson, R., Brown, S.. Moen. R.C., Greenblatt, J., Stewart, P.M., Lcitman. S.F., Wyndham, H.W., Cowan. K., Young. N.S. & Nienhuis, A.W. (1995) Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 85, 30483057.
12. Emmons, R.V., Doren, S.. Zujewski. J., Cottier Fox, M.. Carter, C.S., Hines, K., O'Shaughnessy, J.A.. Leitman, S.F., Greenblatt, J.J., Cowan, K. & Dunbar, C.E. (1997) Retroviral gene transduction of adult peripheral blood or marrow-derived CD34"1" cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood. 89, 4040-4046.
13. Garin. M.. Apperley. J. & Mélo, J. (1996) Ex vivo expansion of human hemopoietic cells from normal bone marrow and peripheral blood from CML patients' (Abstract). Blood, 88, 608a.
14. Gordon, M.Y., Dowding, C.R., Riley, G.P., Goldman, J.M. & Greaves, M.F. (1987) Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature, 328, 342-344.
15. + hematopoietic cells. Human Gene Therapy 8, 2193-2206.
16. Hanenberg. H., Xiao, X.L., Dilloo, D., Hashino, K.. Kato, I. & Williams. D.A. (1996) Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Medicine, 2, 876-882.
17. Hoyle, C.. Gray. R. & Goldman, J. (1994) Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team LRF Centre for Adult Leukaemia. British Journal of Haematology. 86, 76-81.
18. Knaan-Shanzer. S., Valerio, D. & van, B.V. (1996) Cell cycle state, response to hemopoietic growth factors and retroviral vectormediated transduction of human hemopoietic stem cells. Gene Therapy. 3, 323-333.
19. Kotani, H., Newton, P.B., Zhang, S., Chiang, Y.L., Otto, E., Weaver, L., Blaese, R.M., Anderson, W.F. & McGarrity. G.J. (1994) Improved methods of retroviral vector transduction and production for gene therapy. Human Gene Therapy, 5, 19-28.
20. + cells to protect them against alkylating agents. Human Gene Therapy, 8, 1901-1910.
21. + hemopoietic progenitors. Blood. 88, 11681176.
22. Levesque, J.P., Leavesley, D.I., Niutta. S.. Vadas. M. & Simmons, P.J. (1995) Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. Journal of Experimental Medicine, 181, 1805-1815.
23. Markowitz, D., Goff. S., & Bank. A. (1988a) A safe packaging line for gene transfer: separating viral genes on two different plasmids. Journal of Virology. 62, 1120-1124.
24. Markowitz, D., Goff, S. & Bank, A. (1988b) Construction and use of a safe and efficient amphotropic packaging cell line. Virology, 167, 400-406.
25. Mélo, J.V.. Myint. H., Gallon, D.A. & Goldman, J.M. (1994) P190BCR-ABL chronic myeloid leukemia: the missing link with chronic myelomonocytic leukemia? Leukemia, 8, 208-211.
26. Moore, K.A., Deisseroth, A.B., Reading, C.L., Williams, D.E. & Belmont, J.W. (1992) Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood, 79, 1393-1399.
27. Morgenstern, J.R & Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nudeic Acids Research. 18, 3587-3596.
28. Moritz, T., Dutt. P., Xiao. X., Carstanjen, D., Vik, T., Hanenberg, H. & Williams, D.A. (1996) Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood, 88, 855-862.
29. Moritz. T., Patel. V.P. & Williams, D.A. (1994) Bone marrow extracellular matrix molecule? improve gene transfer into human hematopoietic cells via retroviral vectors. Journal of Clinical Investigation. 93, 1451-1457.
30. + cells. British Journal of Uaematology. 102, 759-767.
31. Traycoff, C.M., Srour, E.E, Dutt, P., Fan, Y. & Cornetta, K. (1997) The 30/3 5 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors. Leukemia, 11, 159-167.
32. Verfaillie, C.M., McCarthy, J.B. & McGIave, P.B. (1992) Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia: decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and.collagen type IV. Journal of Clinical Investigation, 90, 1232-1241.
33. + cells. Blood. 84, 1408-1414.
34. Yokota, T., Oritani, K., Mitsui, H., Aoyama, K., Ishikawa, J., Sugahara, H., Matsumura, I., Tsai, S., Tomiyama, Y., Kanakura, Y. & Matsuzawa, Y. (1998) Grouth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: structural requirement for fibronectin activities of CS1 and cell-binding domains. Blood, 91, 3263-3272.
35. Zhao, R.C., Mclvor, R.S., Griffin, J.D. & Verfaillie, C.M. (1997) Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexateresistant and CML progenitors functionally normal and nontumorigenic in vivo. Blood, 90, 4687-4698.